April 10, 2023 06:46 AM EDT
Pharma

Evotec shuts down IT sys­tems in wake of cy­ber­at­tack

Amber Tong

Ger­man drug dis­cov­ery and de­vel­op­ment play­er Evotec came un­der cy­ber­at­tack just be­fore the East­er week­end, the com­pa­ny re­vealed on Fri­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

Strand Ther­a­peu­tics re­ports promis­ing start for mR­NA can­cer ther­a­py

A new dawn for psy­che­delics? Com­pass could be the first to find out

No­var­tis won bid­ding war for kid­ney drug as Reg­u­lus' top three ex­ecs ex­pect to make over $100M com­bined

In­flaRx cans Go­hibic de­vel­op­ment af­ter skin dis­ease tri­al stopped for fu­til­i­ty

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times